Olema Pharmaceuticals, Inc. (OLMA) Financials

$4.57

$0.03 (0.66%)
Last update: 01:00 PM EST
Day's range
$4.45
Day's range
$4.67
$0$0-$50M-$50M-$100M-$100M-$150M-$150MEarning201820182019201920202020202120212022202220232023202420243%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

OLMA Income statement / Annual

Last year (2024), Olema Pharmaceuticals, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Olema Pharmaceuticals, Inc.'s net income was -$129.47 M. See Olema Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $393.00 K $377.00 K $1.66 M $1.66 M $11.00 K $9.03 K $8.24 K
Gross Profit $0.00 -$377.00 K -$1.66 M -$1.66 M -$11.00 K -$9.03 K -$8.24 K
Gross Profit Ratio 0 0 0 0 0 0 0
Research and Development Expenses $124.52 M $86.14 M $82.27 M $51.10 M $13.70 M $3.92 M $1.69 M
General & Administrative Expenses $17.74 M $18.82 M $24.71 M $20.39 M $7.82 M $403.00 K $386.00 K
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $17.74 M $18.82 M $24.71 M $20.39 M $7.82 M $403.00 K $386.00 K
Other Expenses $0.00 $0.00 -$27.00 K -$47.00 K $0.00 $0.00 -$31.00 K
Operating Expenses $142.26 M $104.58 M $106.99 M $71.49 M $21.53 M $4.32 M $2.08 M
Cost And Expenses -$142.26 M $104.96 M $106.99 M $71.49 M $21.53 M $4.32 M $2.08 M
Interest Income $12.68 M $8.33 M $2.23 M $442.00 K $60.00 K $7.00 K $4.00 K
Interest Expense $0.00 $0.00 $0.00 $0.00 $653.00 K $0.00 $28.00 K
Depreciation & Amortization $393.00 K $377.00 K $357.00 K $1.66 M $11.00 K $9.03 K $8.24 K
EBITDA -$129.08 M -$104.58 M -$106.63 M -$69.43 M -$21.52 M -$4.31 M -$2.16 M
EBITDA Ratio 0 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0 0
Total Other Income/Expenses Net $12.78 M $8.31 M $2.20 M $395.00 K -$593.00 K $7.00 K -$118.00 K
Income Before Tax -$129.47 M -$96.66 M -$104.79 M -$71.10 M -$22.12 M -$4.32 M -$2.20 M
Income Before Tax Ratio 0 0 0 0 0 0 0
Income Tax Expense $0.00 $0.00 -$2.20 M -$210.00 K $642.00 K -$155.86 K -$90.00 K
Net Income -$129.47 M -$96.66 M -$104.79 M -$70.89 M -$22.76 M -$4.32 M -$2.20 M
Net Income Ratio 0 0 0 0 0 0 0
EPS -2.2 -2.14 -2.62 -1.79 -0.58 -0.11 -0.16
EPS Diluted -2.2 -2.14 -2.62 -1.79 -0.58 -0.11 -0.16
Weighted Average Shares Out $58.74 M $45.25 M $40.00 M $39.52 M $39.31 M $40.17 M $14.10 M
Weighted Average Shares Out Diluted $58.74 M $45.25 M $40.00 M $39.52 M $39.31 M $40.17 M $14.10 M
Link